Pneumonia Testing Market Size

Pneumonia Testing Market size was valued at USD 688.68 million in 2024 and is projected to exceed USD 1.43 billion by the end of 2037, expanding at over 5.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of pneumonia testing is evaluated at USD 721.19 million.

The growth of the market can be attributed to the rising incidence of pneumonia among the global population. Pneumonia caused 745,280 children to die in 2019, accounting for 14.5% of all pediatric fatalities.

A severe respiratory infection that damages the lungs is termed pneumonia. It is the leading infectious cause of child mortality globally. The little sacs in the lungs called alveoli are stuffed with pus and fluid, when someone with pneumonia inhales, which makes breathing difficult and reduces oxygen intake. Pneumonia can be averted in children, treated with affordable, low-tech medicine, and prevented with streamlined treatments. In 2020, there were 47,601 pneumonia-related fatalities in the U.S. which is equivalent to 14.4 mortalities for every 100,000 people.